1) What
exactly are Pharmacy Benefit Managers?
Pharmacy Benefit Managers are hired by employers, unions,
managed care organizations, government agencies and third party administrators
to manage their prescription drug benefit plans. These organizations are
known as “payers” or “plans”. PBMs also contract with a national network of
pharmacies – typically about 60,000 stores – that will provide or dispense
prescription drugs to plan members and their beneficiaries. PBMs
reimburse the pharmacy network for the negotiated cost of the drug and bill the
payers/plans for the cost usually with what amount to a “mark-up” added to what
was paid to pharmacy. Full service PBMs also provide clinical management
and drug utilization review, disease state management, information service,
claims processing and mail order service.
2) How can a consumer know if their prices
are being affected by PBMs?
Virtually anyone who has insurance is affected. They can
look in their insurance card to see which PBM is managing their drug benefit.
Most of the time, cost increases that result from PBM profiteering are rolled
into the overall health insurance premiums that patients pay and usually
increase year over year. PBMs rarely will provide patients with Explanations of
Benefits (EOB) that will list the drugs and their cost. This will allow
the patient to spot check prices through the internet or at pharmacies.
In the overwhelming majority of cases, the patient only is aware of their
“share” of the drug cost – usually expressed as co-pay or co-insurance.
Patient co-shares, while an important element in the paying for the drug, is a
mere fraction of the actual cost of the drug of which the plan sponsor usually
pays the lion’s share.
3) How do Community Pharmacists fit in?
Community
Pharmacists are an integral part of virtually all PBM national pharmacy
networks, as they operate and dispense prescriptions within local
communities. Of the 60,000 stores that comprise the typical PBM pharmacy
network, more than 23,000 independent community pharmacies and chains are
included. Together they provide more than 315,000 jobs and dispense nearly 40
percent of all retail prescriptions.
PBMs
compete directly with community pharmacies to provide 90-day supplies of
mainetenance medications used to treat chronic conditions such as diabetes,
hypertension, high cholestrol, etc. Patients on complex treatment regimes –
taking multiple maintenance medications – are at high risk of non-adherence
(not taking medications as directed by their doctors). Many of these patients
rely on community pharmacists to provide in-store face-to-face counseling to
help ensure adherence. In fact, study after study has found that this is
the most effective methodology to ensure patient adherence.
PBMs
too often mandate that patients must use PBM-owned mail order pharmacies for
maintenance medications. To promote the usage of mail order, PBMs have
implemented complex co-pay schemes that drive up cost to plans and patients and
often promote the use of more expensive brand drugs whose cost has increased by
27 percent over the last three years.
Mandating
the use of mail order facilities usually disrupts existing patient/pharmacist
relationships that are critical to improving adherence. Non-adherence
represents a $290 billion cost to the U.S. healthcare system because of
increased hospitalizations and ER and doctor office visits. Mail order
pharmacies also dispense cost-saving generic drugs less often than do community
pharmacies. Over the next two (2) years there are nealy $80 billion of
generic savings available to patients and plans.
PBMs
also increase cost to patients and plans through marking-up pharmacy
claims. For example, community pharmacies might get reimbursed $10 for a
generic prescription and the PBM will mark-up the claim to $ 15 for the plan
creating a $5 profit for the PBM. Bear in mind that approximately 4 billion
prescriptions were filled in 2011, so spreads, big and small, really matter and
add to the cost of your prescription benefit.
4) How can consumers protect themselves
from drug pricing scams?
Plan members and their beneficiaries should encourage their
employers and health plans to insist that PBMs provide more transparency to
determine actual drugs costs and how much the PBMs profit from those drugs.
Remember, PBMs don’t pay for your pharmacy benefit – you do. PBMs are
mere middlemen who process claims and provide associated services. The more of
your money the PBMs keep as profit through undisclosed revenue and profit
streams, the higher the cost of providing your pharmacy benefit will be.
Consumers should also actively support legislative and regulatory efforts aimed
at PBMs and ensure that consumes receive the full benefit of the money they
invest in prescription drugs.
5) Who can patients talk to in order to
get more information?
The first stop for all consumers is their benefits
department. Members should ask to review any Explanation of Benefits
(EOB) or any other documentation that relates to their pharmacy benefits. NCPA
provides easy to understand information through its website www.whorunsmydrugplan.com.
No comments:
Post a Comment